PLUR · Pluri Inc. · Financials
$1.08
-0.06 (-5.26%)
At close · Sep 17
Going-concern doubt
— flagged Sep 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“According to management estimates, we have sufficient resources to meet our operating obligations for a period of less than three months from the issuance date of our consolidated financial statements, which was September 10, 2026. These conditions raise substantial doubt about our ability to continue as a going concern.”View the 10-K filed Sep 10, 2026
Market Cap
$15.49M
Shares
12.34M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$1.02M
-24%
FY2026
Net Income
-$23.82M
-5.5%
FY2026
Gross Margin
44.59%
-4.4pp
FY2026
Operating Margin
-2454.53%
-794.6pp
FY2026
Diluted EPS
-$2.44
+31.5%
FY2026
Operating Cash Flow
-$19.59M
-7.6%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.02M | $1.34M | $326K | $287K | $234K | — | $23K | $54K | $50K | — | $2.85M | $379K | $379K | $679K | $716K | — | — | |
| $563K | $682K | $4000 | $9000 | — | — | — | $2000 | $2000 | — | $100K | $13K | $11K | $20K | $21K | — | — | |
| $453K | $654K | $322K | $278K | $234K | — | $23K | $52K | $48K | — | $2.75M | $366K | $368K | $659K | $695K | — | — | |
| 44.59% | 48.95% | 98.77% | 96.86% | 100% | — | 100% | 96.3% | 96% | — | 96.49% | 96.57% | 97.1% | 97.05% | 97.07% | — | — | |
| $15.09M | $12.85M | $12.45M | $15.75M | $24.61M | $30.53M | $23.1M | $29.88M | $26.37M | $24M | $22.86M | $23.42M | $24.94M | $19.91M | $12.69M | $8.31M | $6.12M | |
| $10.3M | $9.98M | $10.03M | $11.78M | $17.45M | $20.56M | $7.92M | $9.16M | $11.19M | $6.93M | $6.49M | $6.46M | $8.68M | $5.65M | $6.57M | $4.49M | $3.14M | |
| $511K | $316K | $253K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$24.94M | -$22.18M | -$22.16M | -$27.25M | -$41.59M | -$50.62M | -$29.48M | -$35.53M | -$33.73M | -$28.02M | -$23.32M | -$25.27M | -$27.85M | -$22.22M | -$15.03M | -$11.11M | -$7.44M | |
| -2454.53% | -1659.88% | -6796.93% | -9493.38% | -17774.79% | — | -128156.52% | -65800% | -67462% | — | -819.07% | -6666.75% | -7348.28% | -3272.9% | -2099.3% | — | — | |
| -$24.43M | -$21.86M | -$21.91M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $932K | $873K | $866K | $843K | $887K | $78K | — | — | — | — | — | — | — | — | — | — | — | |
| $488K | $1.14M | $1.41M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$456K | -$1.08M | $814K | -$1.64M | $219K | $758K | $324K | $225K | $7.61M | $205K | $73K | $590K | $918K | $1.07M | $237K | — | — | |
| -$25.39M | -$23.26M | -$21.34M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$25K | -$5000 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$23.82M | -$22.58M | -$20.89M | -$28.32M | -$41.24M | -$49.87M | -$29.15M | -$35.31M | -$26.13M | -$27.81M | -$23.25M | -$24.68M | -$26.93M | -$21.16M | -$14.79M | -$10.85M | -$7.45M | |
| -2344.59% | -1690.34% | -6407.36% | -9867.94% | -17624.79% | — | -126747.83% | -65383.33% | -52252% | — | -816.51% | -6511.08% | -7106.07% | -3115.61% | -2066.2% | — | — | |
| -$1.55M | -$667K | -$456K | -$566K | -$132K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $9.42B | $6.33B | $5.24B | $28.89M | $41.37M | $49.87M | $29.15M | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | -$29.15M | -$35.31M | -$28.13M | -$27.3M | -$23.91M | -$25.5M | -$24.23M | -$20.77M | -$14.92M | -$10.85M | — | |
| USD/shares | -$2.44 | -$3.56 | -$3.99 | -$6.24 | -$10.24 | -$14.16 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | -$2.44 | -$3.56 | -$3.99 | -$6.24 | -$10.24 | -$14.16 | — | — | — | — | — | — | — | — | — | — | — |
| shares | 9.74M | 6.34M | 5.24M | 4.58M | 4.02M | 3.51M | 2.27M | 1.54M | 1.32M | 1.09M | 9.94M | 8.79M | 7.94M | 6.94M | 5.5M | — | — |
| shares | 9.74M | 6.34M | 5.24M | 4.58M | 4.02M | 3.51M | 2.27M | 1.54M | 1.32M | 1.09M | 9.94M | 8.79M | 7.94M | 6.94M | 5.5M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.76×
EV/EBIT
—
P/E (TTM)
—
Peer median 2.85×
Peer medians compare against the 235 similar-size Biotechnology companies (of 533 listed).